TRAF3IP3

TRAF3IP3 is a compartment-specific adapter protein that orchestrates immune signaling, autophagy, and stress responses by recruiting distinct effectors to the Golgi, lysosomes, mitochondria, and endoplasmic reticulum. At the Golgi, TRAF3IP3 recruits MEK to facilitate BRAF-MEK-ERK activation required for thymocyte positive selection and NKT2 cell maturation (PMID:26195727, PMID:31076725); at lysosomes, it recruits PP2Ac to suppress mTORC1-Raptor signaling and maintain regulatory T cell function (PMID:30115741); and at mitochondria, it bridges TRAF3 to MAVS to enable TBK1-IRF3-driven type I interferon production upon RNA virus sensing, while in myeloid cells it also promotes DTX4-dependent K48-ubiquitination of TBK1 at K372 to negatively regulate IFN-I, revealing cell-type-dependent dual roles in antiviral innate immunity (PMID:31390091, PMID:32366851). TRAF3IP3 additionally promotes autophagy through an ATG16L1-binding motif essential for marginal zone B cell survival (PMID:26011558), recruits STRN3 to the ER to drive PERK/ATF4/CHOP-mediated ER stress and apoptosis (PMID:40068093), and inhibits NEDD4-dependent mitophagy in cardiomyocytes (PMID:39240426).

1. 2003 Medium

   Identification of TRAF3IP3 as a TRAF3-specific adapter that selectively activates JNK — but not NF-κB — established the gene as a signaling scaffold linking TRAF3 to MAP kinase pathways.

   Evidence Co-immunoprecipitation, subcellular fractionation, and reporter assays in transfected cells

   PMID:14572659

   Open questions at the time

   • Interaction shown only with overexpression; endogenous co-IP not reported
   • Physiological cell type and stimulus context unknown
   • Mechanism by which TRAF3IP3 activates JNK not defined
2. 2015 High

   Knockout studies revealed that TRAF3IP3 localizes to the Golgi and recruits MEK to BRAF, providing the mechanistic basis for TCR-stimulated ERK activation during thymocyte positive selection; a constitutively active MEK transgene rescued the selection defect, establishing genetic epistasis.

   Evidence Traf3ip3 knockout mice, genetic rescue with active MEK transgene, Golgi fractionation, co-immunoprecipitation

   PMID:26195727

   Open questions at the time

   • How TRAF3IP3 itself is anchored at the Golgi was not resolved
   • Whether Golgi-localized TRAF3IP3 participates in non-ERK signaling at this compartment is unknown
3. 2015 Medium

   Discovery of an ATG16L1-binding motif in TRAF3IP3 linked the adapter to autophagy and explained the loss of marginal zone B cells and increased apoptosis in knockout mice, broadening its role beyond classical signaling to cellular survival via autophagy.

   Evidence Traf3ip3 knockout mice, autophagy flux assays, ATG16L1-binding motif mutagenesis

   PMID:26011558

   Open questions at the time

   • Direct structural basis for ATG16L1 interaction not determined
   • Whether autophagy function is B cell–specific or generalizable unclear
4. 2018 High

   Demonstration that lysosomal TRAF3IP3 recruits PP2Ac to dephosphorylate the mTORC1 component Raptor explained how TRAF3IP3 restricts mTORC1 and glycolytic metabolism in regulatory T cells, revealing a second compartment-specific adapter function.

   Evidence Treg-specific Traf3ip3 conditional knockout, lysosomal fractionation, PP2Ac–Raptor co-IP, metabolic profiling

   PMID:30115741

   Open questions at the time

   • Signal that directs TRAF3IP3 to lysosomes versus Golgi not identified
   • Whether PP2Ac recruitment operates in non-Treg lineages not tested
5. 2019 High

   Two studies established TRAF3IP3's mitochondrial and Golgi roles in innate and adaptive immunity: upon RNA virus infection it accumulates on mitochondria to bridge TRAF3 to MAVS for TBK1-IRF3-IFN production, and at the trans-Golgi it recruits MEK1 for ERK-driven NKT2 cell maturation.

   Evidence Traf3ip3 KO and T-cell-specific conditional KO mice, viral challenge, co-IP of TRAF3–MAVS, mitochondrial localization, Golgi fractionation

   PMID:31076725 PMID:31390091

   Open questions at the time

   • Stimulus-dependent trafficking signals from Golgi to mitochondria unresolved
   • Whether TRAF3IP3 simultaneously resides at both compartments or redistributes dynamically not determined
6. 2020 High

   In myeloid cells, TRAF3IP3 promotes DTX4-dependent K48-ubiquitination of TBK1 at K372, revealing a negative-feedback mechanism for IFN-I that contrasts with its positive role in lymphoid antiviral signaling and demonstrating cell-type-specific duality.

   Evidence Myeloid-specific Traf3ip3 KO mice, K48-linkage-specific ubiquitination assays, K372 site-directed mutagenesis, viral challenge

   PMID:32366851

   Open questions at the time

   • How TRAF3IP3 switches between promoting and inhibiting TBK1 signaling in different cell types is mechanistically undefined
   • Direct demonstration that DTX4 is the E3 ligase recruited by TRAF3IP3 (rather than correlative) not fully established
7. 2022 Medium

   Identification of TRAF3IP3 as an EV71 3C protease substrate (cleaved at 87Q-88G) showed that a pathogen directly antagonizes TRAF3IP3's antiviral function, and mapped a nuclear export signal contributing to its activity.

   Evidence Yeast two-hybrid, in vitro cleavage assays with site-directed mutagenesis, viral replication assays in Jurkat and RD cells

   PMID:35814660

   Open questions at the time

   • In vivo relevance of EV71-mediated cleavage not confirmed in animal models
   • Whether other picornaviruses also target TRAF3IP3 unknown
8. 2024 Medium

   TRAF3IP3 was found to block NEDD4-dependent mitophagy and promote cardiomyocyte injury during ischemia-reperfusion, extending its functional scope to non-immune tissues and revealing a role in mitochondrial quality control.

   Evidence TRAF3IP3 knockdown in H9C2 cardiomyocytes and rat ischemia-reperfusion model, CHX chase for NEDD4 stability, mitophagy and ATP assays

   PMID:39240426

   Open questions at the time

   • Mechanism by which TRAF3IP3 promotes NEDD4 degradation not characterized
   • Findings from a single lab in one cell line and one in vivo model; independent confirmation lacking
9. 2025 Medium

   IP-MS identification of STRN3 as a direct TRAF3IP3 interactor at the ER, recruited via the TRAF3IP3 transmembrane domain, established a fourth compartment-specific function — driving PERK/ATF4/CHOP ER stress and apoptosis in lung adenocarcinoma cells.

   Evidence IP-MS, co-immunoprecipitation, transmembrane domain mutagenesis, ER stress pathway assays in LUAD cell lines

   PMID:40068093

   Open questions at the time

   • STRN3-dependent ER stress mechanism awaits reconstitution with purified components
   • Relevance beyond lung adenocarcinoma cell lines not established

• The determinants that specify TRAF3IP3 localization to Golgi, lysosomes, mitochondria, or ER — and whether these reflect distinct pools or dynamic redistribution — remain undefined, as does a unifying structural model explaining how one adapter recruits such diverse effectors in a compartment-specific manner.
• No crystal or cryo-EM structure of TRAF3IP3 or its complexes
• Sorting signals directing TRAF3IP3 to specific organelles not mapped
• Cell-type-specific regulation of TRAF3IP3 expression and post-translational modifications not systematically characterized